- Home
- App Analytics
- ParoScan 3Di
- ParoScan 3Di Vs. Xtremity 3D by PAL
ParoScan 3Di vs Xtremity 3D by PAL Uso e estatísticas
FOCUS ON QUALITY AND QUALITY
The paroScan 3D is the cost-effective alternative to plantar scanning of feet and scanning of foam impressions using a 3D scanner. With the paroScan 3D, users without high coverage numbers can use modern 3D technology. Because in conjunction with an iPad, this scanner becomes an affordable and mobile 3D scanning unit.
CONVINCING IN PRICE AND PERFORMANCE
The paroScan 3D is a powerful device for modern, mobile foot care:
Easy installation and handling
Innovative technology
Suitable app for innovative work
PROGRAMMED FOR COST-EFFICIENCY
The powerful paromed app enables users to work cost-effectively and time-saving: scans can be displayed on the iPad and made available for direct import into the paroManager. And that in the right paromed format, as the 3D scanner fits seamlessly into the paroContour software and no post-processing is necessary.
COMPATIBLE iPads
Please double check what iPads can be used with the Structure Sensor scanner before downloading the app.
Terms of Use: https://www.apple.com/legal/internet-services/itunes/dev/stdeula/
- Apple App Store
- Gratuitos
- Médico
Ranking da Loja
- -
PAL Health Technologies 3D scanning application for ordering orthotics. The easy way to scan and place orders for custom orthotics from PAL Health Technologies. Fast, clean, and user friendly application.
- Apple App Store
- Gratuitos
- Médico
Ranking da Loja
- -
ParoScan 3Di versus Xtremity 3D by PAL comparação de classificação
Compare a tendência de classificação de ParoScan 3Di nos últimos 28 dias versus Xtremity 3D by PAL
Classificação
Nenhum dado disponível
Comparação da classificação de ParoScan 3Di vs. Xtremity 3D by PAL por país
Compare a tendência de classificação de ParoScan 3Di nos últimos 28 dias versus Xtremity 3D by PAL
Nenhum dado para exibir
Faça comparações com qualquer site com o nosso teste grátis
ParoScan 3Di VS.
Xtremity 3D by PAL
13ezembro d, 2024